Patents by Inventor Anthony P. West

Anthony P. West has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for interacting with overlapping regions of interest in machine vision applications
    Patent number: 11966569
    Abstract: Example systems and methods for interacting with overlapping regions of interest (ROIs) in machine vision applications are disclosed. An example system includes a machine vision camera, and a client computing device coupled to the machine vision camera. The client computing device configured to: receive an image from the machine vision camera; present the image on a canvas, wherein the canvas is part of a first user interface of a machine vision application displayed on the client computing device; present a first ROI associated with a first machine vision tool on the canvas; present a second ROI associated with a second machine vision tool on the canvas; and target the first ROI or the second ROI as a targeted ROI for interaction based upon distances from a pointer displayed on the canvas to features of the first ROI and the second ROI.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: April 23, 2024
    Assignee: Zebra Technologies Corporation
    Inventors: Matthew M. Degen, Anthony P. DeLuca, Christopher M. West
  • THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2
    Publication number: 20240083982
    Abstract: Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection.
    Type: Application
    Filed: July 21, 2023
    Publication date: March 14, 2024
    Inventors: Barry D. Olafson, Stephen L. Mayo, Pamela J. Bjorkman, Jost G. Vielmetter, Justin W. Chartron, Paul M. Chang, Stephanie C. Contreras, Jingzhou Wang, Aiden J. Aceves, Anthony P. West, Jr., Christopher O. Barnes, Jennifer R. Keeffe, Claudia A. Jette
  • ANTIBODIES TARGETING HIV ESCAPE MUTANTS
    Publication number: 20220169707
    Abstract: Embodiments of the present invention are directed to compositions and methods for anti-HIV (anti-CD4 binding site) broadly neutralizing antibodies having improved potency and breadth for neutralizing a range of HIV strains. Combinations of broadly neutralizing antibodies can also improve potency over a single antibody composition.
    Type: Application
    Filed: October 13, 2021
    Publication date: June 2, 2022
    Applicants: The Rockefeller University, California Institute of Technology
    Inventors: Ron Diskin, Anthony P. West, Michel Nussenzweig, Pamela J. Bjorkman
  • HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants
    Patent number: 11149081
    Abstract: Embodiments of the present invention are directed to compositions and methods for anti-HIV (anti-CD4 binding site) broadly neutralizing antibodies having improved potency and breadth for neutralizing a range of HIV strains. Combinations of broadly neutralizing antibodies can also improve potency over a single antibody composition.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: October 19, 2021
    Assignees: THE ROCKEFELLER UNIVERSITY, CALIFORNIA INSTITUTE OF TECHNOLOGY
    Inventors: Ron Diskin, Anthony P. West, Michel C. Nussenzweig, Pamela J. Bjorkman
  • ANTIBODIES TARGETING HIV ESCAPE MUTANTS
    Publication number: 20180230203
    Abstract: Embodiments of the present invention are directed to compositions and methods for anti-HIV (anti-CD4 binding site) broadly neutralizing antibodies having improved potency and breadth for neutralizing a range of HIV strains. Combinations of broadly neutralizing antibodies can also improve potency over a single antibody composition.
    Type: Application
    Filed: December 7, 2017
    Publication date: August 16, 2018
    Inventors: Ron Diskin, Anthony P. West, Michel C. Nussenzweig, Pamela J. Bjorkman
  • Antibodies targeting HIV escape mutants
    Patent number: 9879068
    Abstract: Embodiments of the present invention are directed to compositions and methods for anti-HIV (anti-CD4 binding site) broadly neutralizing antibodies having improved potency and breadth for neutralizing a range of HIV strains. Combinations of broadly neutralizing antibodies can also improve potency over a single antibody composition.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: January 30, 2018
    Assignees: California Institute of Technology, The Rockefeller University
    Inventors: Ron Diskin, Anthony P. West, Michel C. Nussenzweig, Pamela J. Bjorkman
  • CROSSLINKED ANTI-HIV-1 COMPOSITIONS FOR POTENT AND BROAD NEUTRALIZATION
    Publication number: 20160102137
    Abstract: An anti-HIV-1 spike composition includes a first anti-HIV-1 antibody Fab and a second anti-HIV-1 antibody Fab linked by a DNA or protein linker molecule to form a crosslinked homo-diFab or hetero-diFab having improved viral potency and neutralization. The anti-HIV-1 antibody Fabs include anti-gp120 CD4, anti-gp120 V1V2, anti-gp120 V3, and anti-gp41.
    Type: Application
    Filed: September 30, 2015
    Publication date: April 14, 2016
    Inventors: Pamela J. Bjorkman, Rachel P. Galimidi, Anthony P. West, Michel C. Nussenzweig
  • ANTIBODIES TARGETING HIV ESCAPE MUTANTS
    Publication number: 20140017234
    Abstract: Embodiments of the present invention are directed to compositions and methods for anti-HIV (anti-CD4 binding site) broadly neutralizing antibodies having improved potency and breadth for neutralizing a range of HIV strains. Combinations of broadly neutralizing antibodies can also improve potency over a single antibody composition.
    Type: Application
    Filed: June 21, 2013
    Publication date: January 16, 2014
    Inventors: Ron Diskin, Anthony P. West, Michel C. Nussenzweig, Pamela J. Bjorkman
  • METHODS FOR CREATING OR IDENTIFYING COMPOUNDS THAT BIND TUMOR NECROSIS FACTOR ALPHA
    Publication number: 20120094935
    Abstract: Methods for creating therapeutic candidate compounds or of identifying therapeutic candidate compounds for use in treating TNF?-mediated diseases or conditions are described that utilize parameters, including amino acid residues, obtained by analysis of a Yatapoxvirus 2L-TNF? crystal structure.
    Type: Application
    Filed: April 9, 2010
    Publication date: April 19, 2012
    Inventors: Anthony P. West, Zhiru Yang, Pamela J. Bjorkman